Erdafitinib in Metastatic Steroid-cell Ovarian Cancer
Clinical trial NCT06328491 · COMPLETED
Trial details
- NCT number
- NCT06328491
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2022-08-22
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.